Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.2% while the Hang Seng is up 0.7%. The Shanghai Composite is trading up by 1.4%. The three major US stock indices closed higher on Monday as investors applauded a strong US earnings season with results from Berkshire Hathaway impressing and Facebook lifting Nasdaq after a report it was planning new services.
Back home, India share markets have opened the day on a flat note. The BSE Sensex is trading up by 35 points while the NSE Nifty is trading up by 17 points. The BSE Mid Cap index opened and BSE Small Cap index opened the day up by 0.4% & 0.2% respectively.
The rupee is currently trading at 68.68 to the US$.
Sectoral indices have opened the in on a mixed note with metal stocks and automobile stocks witnessing maximum buying interest. While, bank stocks and power stocks have opened the day in the red.
In the news from the pharma sector. As per an article in a leading financial daily, Sun Pharma, has launched Kapspargo Sprinkle in the US. The drug is used in the treatment of chest pain, heart failure and high blood pressure.
Reportedly, the metoprolol succinate extended-release tablets have sales of around US$600-700 million sales per annum in US.Kapspargo Sprinkle, approved by USFDA is a patented formulation of metoprolol succinate, the only extended-release sprinkle formulation of the beta1-selective adrenoreceptor blocking agent called beta-blocker.
Kapspargo Sprinkle pellets can be sprinkled over soft food or administered via a nasogastric tube, and are designed to facilitate long-term, once-daily administration, particularly for patients who have difficulty in swallowing tablets.
Kapspargo Sprinkle capsules may make it easier for patients to take their antihypertensive medication. This innovative product is the latest example of Sun Pharma’s use of advanced technology to create novel formulations.
